Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zoetis Inc ZTS

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a... see more

Recent & Breaking News (NYSE:ZTS)

Media Advisory: Ribbon Cutting Ceremony for new Zoetis facility in Lincoln, NE, to expand manufacturing capabilities and bring more jobs to Lincoln

Business Wire August 9, 2023

Zoetis Announces Second Quarter 2023 Results

Business Wire August 8, 2023

Media Advisory: Ribbon Cutting Ceremony for new Zoetis facility in Lincoln, NE, to expand manufacturing capabilities and bring more jobs to Lincoln

Business Wire August 4, 2023

Zoetis Named One of the Best Workplaces for Innovators by Fast Company

Business Wire July 12, 2023

Zoetis Announces Appointment of Ester Banque as President of U.S. Operations for World Leader in Animal Health

Business Wire July 10, 2023

Zoetis to Host Webcast and Conference Call on Second Quarter 2023 Financial Results

Business Wire June 30, 2023

Zoetis Releases 2022 Sustainability Report to Share Progress in Building a Better Future for People, Animals and the Planet

Business Wire June 15, 2023

Zoetis to Participate in the Stifel 2023 Jaws and Paws Conference

Business Wire May 30, 2023

Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade

Business Wire May 25, 2023

Zoetis Declares Third Quarter 2023 Dividend

Business Wire May 11, 2023

Zoetis Announces U.S. FDA Approval of Librela(TM) (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs

Business Wire May 5, 2023

Zoetis Announces First Quarter 2023 Results

Business Wire May 4, 2023

Zoetis Announces Date for 2023 Investor Day

Business Wire May 1, 2023

Zoetis Foundation Announces First Round of 2023 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Well-being

Business Wire April 5, 2023

Zoetis to Host Webcast and Conference Call on First Quarter 2023 Financial Results

Business Wire March 30, 2023

Zoetis Named One of the World's Most Ethical Companies by Ethisphere

Business Wire March 13, 2023

Zoetis to Participate in the TD Cowen Health Care Conference

Business Wire March 3, 2023

Zoetis Secures $15.3 Million Grant to Advance Sustainable Livestock Production and Improve Livelihoods in Sub-Saharan Africa

Business Wire March 1, 2023

Zoetis to Participate in the Bank of America Securities 2023 Animal Health Summit

Business Wire February 28, 2023

Zoetis Reports Fourth Quarter and Full Year 2022 Results

Business Wire February 14, 2023